跳至主要内容
临床试验/NCT06342557
NCT06342557招募中不适用

Integrated System for Patients Who Belong the Transition to Adult Services and Are Undergoing a Liver Transplant

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2024年3月28日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250
试验地点
1
主要终点
four-item Morisky Medication Adherence Scale (MGLS)

研究概览

简要总结

The study is part of the MACROLIVER Project, whose main objective is to create a digital tool for patients and caregivers for the management of liver disease that allows the optimization of therapy and/or the treatment process, even remotely. Such a tool not only reduces the movement of patients who are by definition fragile, but also enables the optimization of access and care by a multidisciplinary team. This tool is intended to support doctors and patients, but in no way replaces normal clinical practice. This study aims to explore the specificities of patients experiencing the transition from the pediatric ward to the adult ward in order to identify risk and protective factors that influence psychological well-being at both an individual and relational level. In order to gather all the information about the patients attending the transitional clinic and to obtain a more complete and truthful clinical-psychological picture, the study also includes the collection of retrospective data of the transplanted patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
14 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • patients between the ages of 14 and 20 who have been transplanted at the ASST-PG23 transplant center or are awaiting a liver transplant and belong to the transition to adult services
  • signed informed consent
  • proven use of the APPs (to be assessed based on the last 2 weeks)

排除标准

  • 未提供

结局指标

主要结局

four-item Morisky Medication Adherence Scale (MGLS)

时间窗: 3 months

MGLS is used to assess non-adherence to therapy. The MGLS includes four questions with yes/no response options, resulting in a score from 0 to 4. Based on this score, there are 3 levels of adherence: high, medium and low adherence with 0, 1-2 and 3-4 points respectively. Scores below 2 indicate a lack of adherence to therapy, while scores greater than or equal to 3 indicate adherence to therapy.

次要结局

未报告次要终点

研究者

发起方
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Transitional ePRO Diary Liver | 临床试验